Full text
PDF

Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Anderson J. V., Donckier J., Payne N. N., Beacham J., Slater J. D., Bloom S. R. Atrial natriuretic peptide: evidence of action as a natriuretic hormone at physiological plasma concentrations in man. Clin Sci (Lond) 1987 Mar;72(3):305–312. doi: 10.1042/cs0720305. [DOI] [PubMed] [Google Scholar]
- Bolli P., Müller F. B., Linder L., Raine A. E., Resink T. J., Erne P., Kiowski W., Ritz R., Bühler F. R. The vasodilator potency of atrial natriuretic peptide in man. Circulation. 1987 Jan;75(1):221–228. doi: 10.1161/01.cir.75.1.221. [DOI] [PubMed] [Google Scholar]
- Cappuccio F. P., Markandu N. D., Sagnella G. A., MacGregor G. A. Sodium restriction lowers high blood pressure through a decreased response of the renin system--direct evidence using saralasin. J Hypertens. 1985 Jun;3(3):243–247. doi: 10.1097/00004872-198506000-00008. [DOI] [PubMed] [Google Scholar]
- Sagnella G. A., Markandu N. D., Shore A. C., Forsling M. L., MacGregor G. A. Plasma atrial natriuretic peptide: its relationship to changes in sodium intake, plasma renin activity and aldosterone in man. Clin Sci (Lond) 1987 Jan;72(1):25–30. doi: 10.1042/cs0720025. [DOI] [PubMed] [Google Scholar]
